The companies will collaborate with AstraZeneca to advance local lab testing for a prostate cancer genomic instability ...

Nabsys launches RepX, a pipeline on its Navigator platform that analyzes up to 23 disease loci in one run using Electronic ...

Beckman Coulter Diagnostics appoints Catherine Jennings, formerly of Boston Scientific as president to lead global operations ...

A peer-reviewed study validates Gnosis' EdenDx cervical sample test, showing 96.8% specificity for endometrial cancer ...

Aignostics launches HETA Clinical, an AI suite for assessing H&E slide quality and tumor content, aiming to reduce failed ...

Biodesix is presenting data showing Nodify Lung assay’s integration with PET imaging and its impact on lung nodule diagnostic ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...

Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...

Labcorp to acquire select BioReference Health assets from OPKO Health for $722 million, including labs, service centers, and ...

Keck Medicine of USC has begun a trial to assess a blood test for early breast cancer detection, evaluating its use alongside ...

New studies presented at ACG 2026 indicate TissueCypher offers objective risk assessment for Barrett’s esophagus progression ...

A study found plasma %p-tau217 reliably identified elevated brain amyloid across diverse groups, supporting its use in ...